文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

转化脓毒症研究:跨越鸿沟

Translational Sepsis Research: Spanning the Divide.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论脓毒症生物学知识快速增长,但60余项新疗法临床试验均未发现获益;实验室与临床研究之间的鸿沟可能通过系统针对已识别的转化差距来弥合。

该文为综述,通过MEDLINE检索相关文献并经作者共识选取原创研究、综述和系统评价,综合评述将脓毒症实验动物模型转化至床旁的挑战。作者首先提出脓毒症反应动力学的异质性是一种重要、常被低估但可克服的转化障碍,随后讨论动物实验与临床试验在假设检验要素上的差异:队列选择、把握度与样本量、随机化与盲法、干预时机。在此基础上,作者提出一个情境框架以推进基于动物的研究范式,促进从分子到医学的转化。结论认为实验室与临床研究领域之间存在持续鸿沟,可能通过系统针对已识别的转化差距来弥合。

要点

  • 脓毒症护理的支柱仍为抗生素、液体复苏和衰竭器官系统的生理支持,尽管分子机制知识呈指数增长。
  • 超过60项新疗法临床试验在生物学数据强力支持下开展,均未能发现获益。
  • 脓毒症反应动力学的异质性被作者视为重要、常被低估但可克服的转化障碍来源。
  • 动物实验与临床试验在队列选择、把握度与样本量、随机化与盲法、干预时机等假设检验要素上存在差异。
  • 作者提出情境框架以推进动物研究范式,促进从分子到医学的转化。

研究设计与关键结果

  • 研究类型:综述;通过MEDLINE检索已发表科学文献,经作者共识选取原创研究、综述和系统评价。
  • 核心观察:脓毒症分子机制知识呈指数增长,但护理支柱仍为抗生素、液体复苏和衰竭器官系统的生理支持。
  • 超过60项新疗法临床试验在提示临床效用的生物学数据支持下开展,均未能发现获益。
  • 作者提出脓毒症反应动力学异质性是重要、常被低估但可克服的转化障碍来源。
  • 作者讨论动物实验与临床试验在队列选择、把握度与样本量、随机化与盲法、干预时机上的差异。
  • 作者提出情境框架以推进基于动物的研究范式,促进从分子到医学的转化。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Our knowledge of the molecular mechanisms of sepsis has attained exponential growth. Yet, the pillars of its care remain antibiotics, fluid resuscitation, and physiologic support of failing organ systems. The inability to bring biologic breakthroughs to the bedside is not for lack of effort. Over 60 clinical trials of novel therapies, each heavily supported by the momentum of biologic data suggesting clinical utility, have been conducted and have failed to identify benefit. This mass of "negative" clinical data abut an equally towering mound of knowledge of sepsis biology, which collectively have led investigators to ask, "what happened?"

DATA SOURCES: Review of published scientific literature via MEDLINE searches using key terms related to the article topics.

STUDY SELECTION: Original articles, review articles, and systematic reviews were considered.

DATA EXTRACTION: Articles were selected for inclusion based upon author consensus.

DATA SYNTHESIS: Here, we present a synthetic review of some of the challenges in translating experimental animal models of sepsis to the bedside. We commence with the concept that the heterogeneity in the kinetics of the sepsis response serves as an important, often underappreciated but surmountable, source of translational impedance. Upon this groundwork, we discuss distinctions between animal experimentation and clinical trial design in the elements for hypothesis testing: cohort selection, power and sample size, randomization and blinding, and timing of intervention. From this concept, we develop a contextual framework for advancing the paradigm of animal-based investigations to facilitate science that transitions from molecule to medicine.

CONCLUSIONS: A persistent divide exists between the laboratory and clinical research arenas, which may be addressable via systematic targeting of identified translational gaps.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lewis AJ, Lee JS, Rosengart MR, et al. Translational Sepsis Research: Spanning the Divide. Crit Care Med. 2018. PMID: 30113370. doi:10.1097/CCM.0000000000003271

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。